Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000311:Adrenal Glands / Q000201:enzymology; D000616:Aminoglutethimide / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology*; D000927:Anticonvulsants / Q000494:pharmacology*; D002940:Circadian Rhythm; D003480:Cushing Syndrome / Q000652:urine*; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D011276:Pregnanediol / Q000652:urine; D011278:Pregnanes / Q000652:urine; D011279:Pregnanetriol / Q000652:urine; D011728:Pyridones / Q000494:pharmacology*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000814:Aniline Compounds; D000927:Anticonvulsants; D011278:Pregnanes; D011728:Pyridones; D000616:Aminoglutethimide; D011279:Pregnanetriol; D006899:Mixed Function Oxygenases; D011276:Pregnanediol